These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18038876)

  • 21. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?
    Simon RM; Howard LE; Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Vidal AC
    BJU Int; 2016 Jun; 117(6):897-903. PubMed ID: 26010251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical recurrence after radical prostatectomy with or without pelvic lymphadenectomy in Korean men with high-risk prostate cancer.
    Ku JH; Jeong CW; Park YH; Cho MC; Kwak C; Kim HH
    Jpn J Clin Oncol; 2011 May; 41(5):656-62. PubMed ID: 21430020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
    Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
    J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
    Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC
    Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience.
    Liauw SL; Webster WS; Pistenmaa DA; Roehrborn CG
    Urology; 2003 Jun; 61(6):1204-10. PubMed ID: 12809898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy.
    Moschini M; Sharma V; Gandaglia G; Dell'Oglio P; Fossati N; Zaffuto E; Montorsi F; Briganti A; Karnes RJ
    BJU Int; 2017 Jul; 120(1):69-75. PubMed ID: 27753192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients.
    Spiotto MT; Hancock SL; King CR
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):54-61. PubMed ID: 17459606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
    Hackman G; Taari K; Tammela TL; Matikainen M; Kouri M; Joensuu T; Luukkaala T; Salonen A; Isotalo T; Pétas A; Hendolin N; Boström PJ; Aaltomaa S; Lehtoranta K; Hellström P; Riikonen J; Korpela M; Minn H; Kellokumpu-Lehtinen PL; Pukkala E; Hemminki A;
    Eur Urol; 2019 Nov; 76(5):586-595. PubMed ID: 31375279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
    Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
    Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
    Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors.
    Chawla AK; Thakral HK; Zietman AL; Shipley WU
    Urology; 2002 May; 59(5):726-31. PubMed ID: 11992848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of biochemical recurrence after radical prostatectomy. New tool for selecting candidates for adjuvant radiation therapy.
    Herranz-Amo F; Molina-Escudero R; Ogaya-Pinies G; Ramírez-Martín D; Verdú-Tartajo F; Hernández-Fernández C
    Actas Urol Esp; 2016 Mar; 40(2):82-7. PubMed ID: 26424411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy.
    Kalapurakal JA; Huang CF; Neriamparampil MM; Small WJ; Pins MR; Mittal BB; Campbell SC; Grayhack JT; Shetty RM
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1047-54. PubMed ID: 12419430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Tomaszewski JE; Wein A
    Cancer; 2000 May; 88(9):2110-5. PubMed ID: 10813723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implication of staging of seminal vesicle invasion in patients with prostatic adenocarcinoma after prostatectomy.
    Fukunaga A; Maejima A; Shinoda Y; Matsui Y; Komiyama M; Fujimoto H; Miyagi Maeshima A
    Int J Urol; 2021 Oct; 28(10):1039-1045. PubMed ID: 34291506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy.
    Kim BS; Lashkari A; Vongtama R; Lee SP; Parker RG
    Clin Prostate Cancer; 2004 Sep; 3(2):93-7. PubMed ID: 15479492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
    Pisansky TM; Agrawal S; Hamstra DA; Koontz BF; Liauw SL; Efstathiou JA; Michalski JM; Feng FY; Abramowitz MC; Pollack A; Anscher MS; Moghanaki D; Den RB; Stephans KL; Zietman AL; Lee WR; Kattan MW; Stephenson AJ; Tendulkar RD
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1046-1053. PubMed ID: 27745980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.